靶本比测量能否用FDG PET检测并准确定量动脉粥样硬化?很可能不能
该文讨论FDG PET在动脉粥样硬化斑块检测与定量中的作用,指出PET空间分辨率欠佳限制微小斑块的显示,且FDG在血池中滞留时间长导致结果不理想;靶本比(TBR)虽被提出用于校正这一误差,但其数值随图像采集时间明显变化,延迟显像(3–4小时)或可免除TBR测量但常规PET仪器难以实施;18F-氟化钠(NaF)对钙化高度特异且快速清除,可准确测定心脏或全身大动脉的动脉粥样硬化总负荷,因此目前FDG PET的TBR测量用于斑块检测与定量的价值存疑。
要点
- FDG PET空间分辨率欠佳,难以显示体积很小的斑块。
- TBR数值随图像采集时间明显变化,延迟显像(3–4小时)常规PET仪器难以实施。
- NaF对钙化高度特异且快速清除,可准确测定心脏或全身大动脉的动脉粥样硬化负荷。
核心结论
- 目前FDG PET的TBR测量用于动脉粥样硬化斑块检测与定量的价值存疑。
研究设计与样本
- 该文为论述性文章,围绕FDG PET的TBR测量与NaF PET在动脉粥样硬化检测与定量中的作用展开讨论。
主要发现
- FDG PET的空间分辨率欠佳,限制其对体积很小斑块的显示。
- FDG在血液中滞留时间延长,因此提供的结果不理想。
- TBR数值随图像采集时间不同而明显变化。
- 延迟显像(3–4小时)或可免除TBR测量,但常规PET仪器难以实施。
- NaF对钙化高度特异且快速从循环中清除,可准确测定心脏或全身大动脉的动脉粥样硬化总负荷。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The introduction of FDG in 1976 started a new discipline and enhanced the role of molecular imaging in medicine. While the initial intent with this tracer was to determine brain function in a variety of neuropsychiatric disorders, over time, this powerful approach has made a major impact on managing many other diseases and disorders. During the past 2 decades, FDG PET has been used to detect inflammatory lesions in the atherosclerotic plaques and in other settings. However, the suboptimal spatial resolution of PET limits its ability to visualize plaques that are very small in size. Furthermore, this tracer remains in the blood for an extended period and therefore provides suboptimal results. Target-to-background ratio (TBR) has been suggested to correct for this source of error. Unfortunately, TBR values vary substantially, depending on the timing of image acquisition. Delayed imaging at later time points (3-4 hours) may obviate the need for TBR measurement, but it is impractical with conventional PET instruments. Recently, 18F-sodium fluoride (NaF) has been used for detection and quantification of molecular calcification in the plaques. This tracer is highly specific for calcification and is rapidly cleared from the circulation. In addition, global atherosclerotic burden as measured by NaF PET can be determined accurately either in the heart or major arteries throughout the body. Therefore, the role of FDG PET-based TBR measurement for detection and quantification of atherosclerotic plaques is questionable at this time.
引用
- Alavi A, Werner TJ, Høilund-Carlsen PF, et al. Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not. Clin Nucl Med. 2022. PMID: 35384906. doi:10.1097/RLU.0000000000004131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。